Suchergebnisse - "Kayser, Sabine"

PubPharm (15)

1

Q-HAM : a multicenter upfront randomized phase II trial of quizartinib and high-dose Ara-C plus mitoxantrone in relapsed/refractory AML with FLT3-ITD

enthalten in: Trials | 2023

von Jaramillo, S. | Le Cornet, L. | Kratzmann, M. | +23

2

Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease

enthalten in: Journal of hematology & oncology | 2023

von Heitmann, J. | Schlenk, R. | Dörfel, D. | +15

3

Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD : results from an international collaborative study

enthalten in: Haematologica | 2022

von Kayser, S. | Kramer, M. | Martínez-Cuadrón, D. | +21

CommentIn: Haematologica. 2022 Apr 01;107(4):783-784. - PMID 34348456

4

A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia

enthalten in: Blood advances | 2020

von Smith, C. | Levis, M. | Frankfurt, O. | +13

5

Midostaurin : a multiple tyrosine kinases inhibitor in acute myeloid leukemia and systemic mastocytosis

enthalten in: Small molecules in hematology | 2018

von Schlenk, R. | Kayser, S.

6

Midostaurin : A Multiple Tyrosine Kinases Inhibitor in Acute Myeloid Leukemia and Systemic Mastocytosis

enthalten in: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer | 2018

von Schlenk, R. | Kayser, S.

7

Midostaurin treatment in FLT3-mutated acute myeloid leukemia and systemic mastocytosis

enthalten in: Expert review of clinical pharmacology | 2017

von Kayser, S. | Levis, M. | Schlenk, R.

8

A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations

enthalten in: British journal of haematology | 2015

von Fiedler, W. | Kayser, S. | Kebenko, M. | +13

9

Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation

enthalten in: Blood | 2014

von Schlenk, R. | Kayser, S. | Bullinger, L. | +23

CommentIn: Blood. 2014 Nov 27;124(23):3341-2. - PMID 25431476

10

FLT3 tyrosine kinase inhibitors in acute myeloid leukemia : clinical implications and limitations

enthalten in: Leukemia & lymphoma | 2014

von Kayser, S. | Levis, M.